MDMA Statement on House Ways and Means Committee Markup of Legislation to Repeal the Medical Device Tax
Washington, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the House Ways and Means Committee markup of H.R. 160, the “Protect Medical Innovation Act of 2015," which would repeal the medical device excise tax:
"MDMA warned in 2009 that a medical device excise tax would thwart innovation and patient care, and sadly, these predictions have come true. Fortunately, there continues to be growing bipartisan support in Congress to repeal this onerous policy, which would allow medical technology innovators to invest more resources in the cures and therapies of tomorrow while creating new high-tech manufacturing jobs.
"MDMA remains dedicated to working with Congress and the diverse coalition of stakeholders to get repeal of the device tax across the finish line once and for all, and today's vote is an important step on this journey."